Skip to main content
Main analysis: Geshem Lamishtaken in 2025: Projects Are Moving, but Expensive Financing Still Sets the Pace
ByMarch 31, 2026~9 min read

Geshem Lamishtaken: Woltstone, the Bond Stack, and the Maturity Wall

The main article argued that financing is still the active bottleneck at Geshem Lamishtaken. This follow-up shows why: Woltstone is not just equity-gap debt but a claim on project profits, and the Series B expansion bought time without erasing the maturity wall.

CompanyGeshem

What Matters First

The main article argued that financing is still the active bottleneck at Geshem Lamishtaken. This follow-up isolates the capital structure itself, because as of December 31, 2025, the group was not facing one debt problem but a layered maturity wall: ILS 362.2 million of short-term bank credit, ILS 322.5 million of short-term credit from financial institutions and others, ILS 159.8 million in the line that combines Woltstone and its share in project profits, and another ILS 47.5 million of current Series A bond maturities. Outside the bonds, there was almost no long-term external financing left: only ILS 2.8 million.

That is the right framing. Not every shekel in that wall carries the same risk. Most bank debt sits inside closed project-finance structures. Series A is tied to surplus from three specific projects. Series B pushes principal out to 2028 and 2029. Woltstone sits in between: less senior than bank debt, less clean than public bonds, and most importantly, it does not stop at interest. It also reaches into project economics.

The post-balance-sheet sequence makes that clear. On January 1, 2026, the company paid Woltstone ILS 25 million of principal. On February 17, 2026, it expanded Series B by ILS 25 million par value for gross proceeds of ILS 25.45 million. On March 31, 2026, it paid about ILS 30.2 million of Series A principal and interest. In all-in cash-flexibility terms, the three disclosed moves already amount to a net cash outflow of roughly ILS 29.7 million, before the remaining Woltstone principal of about ILS 39 million that was scheduled for April 1, 2026, and before the roughly ILS 66 million of accrued interest that was deferred to the earlier of June 30, 2026 or 90 days after lender notice. The disclosed materials do not confirm whether the April 1 balance was actually repaid, which is why the maturity wall still matters.

The real issue, then, is not only the cost of debt. It is which layer gets the project surplus first. As long as that order of claims is not unwound, reported gross profit does not automatically become balance-sheet flexibility.

Balance-sheet maturity wall as of December 31, 2025

Woltstone: Not Just Mezzanine

It is tempting to label Woltstone as mezzanine financing and move on. That misses the real economics. This obligation is measured not only as principal and base interest, but also as Woltstone's share of profits in the projects it financed. In projects funded through its partnerships, it is entitled to 50% of profits. In subsidized housing projects where up to 20% of the project-company equity was allocated to the contractor, its share falls to 40%. That is why the ILS 159.8 million balance-sheet line is not "just another loan." It is a hybrid layer of debt, accrued interest, and project profit participation.

The company even quantifies the sensitivity. A ILS 1 million increase or decrease in expected profit in each relevant project over successive periods changes consolidated finance expense by about ILS 1.4 million, discounted to the reporting date. In other words, when projected project margin moves, Woltstone moves through finance expense almost immediately. That makes it structurally different from both the banks and the bonds.

The four reportable Woltstone loans show where the pressure sits. Ono Center alone stood at about ILS 96 million of principal and interest as of December 31, 2025. The three Moradot Arnona projects in Jerusalem added about ILS 29 million more. Effective rates on those loans range between 6.93% and 9.26%. But pricing is only part of the story. The agreements sit on second-ranking liens, company and sponsor guarantees, and a far more intrusive restriction package than a quiet debt line: limits on changes in ownership or structure, share issuances, liens, guarantees, shareholder loans, dividends, and payments to controlling shareholders and related entities without Woltstone approval.

Material Woltstone loans as of December 31, 2025

There is another important layer here. The company committed not to remove surplus liens from certain projects as long as those liens continue to secure other Woltstone obligations. That matters because it separates accounting surplus from surplus that is actually free to move. Even when one specific loan gets close to repayment, the associated surplus does not necessarily become immediately available to the rest of the capital stack.

And this is no longer a growth engine. The company says Woltstone stopped financing new company projects after the Jerusalem projects. That means Woltstone in 2026 looks less like a future funding channel and more like a legacy overhang that has to be dismantled. The July 2025 extension did not remove the problem. It spread it out: ILS 20 million by October 1, 2025, another ILS 25 million by January 1, 2026, and the remaining principal of about ILS 39 million by April 1, 2026. The first two payments were disclosed as completed. The third date has already passed, but the disclosed materials do not confirm whether the balance was actually paid. That is exactly what a real maturity wall looks like.

The Bond Stack: Series B Bought Time, Series A Still Depends on Specific Surplus

The two bond series play a very different role from Woltstone. At year-end 2025, Series A carried ILS 47.5 million, all classified as current maturities. Series B carried ILS 73.8 million, with no current principal. After the February 2026 private placement, Series B par outstanding rose from ILS 75 million to ILS 100 million.

The key distinction is not only duration. It is collateral. Series A is secured by expected surplus from the Kiryat Motzkin Meshkanot HaOmanim project, Dimona Phase A, and Jisr al-Zarqa Phase B. This is a bond series whose repayment is directly linked to how quickly surplus is released from those specific projects. Series B, by contrast, is unsecured. Its protection comes from covenants and a negative pledge against creating a floating charge. So the Series B expansion was a duration move and a balance-sheet-discipline move, not a collateral move.

That is why the February 2026 private placement matters, but does not solve the whole problem. The company raised ILS 25.45 million gross from seven qualified investors at ILS 1.018 per ILS 1 par value. That is funding that lands in the longer-dated corporate debt layer, with principal not starting until June 30, 2028. But it does not reduce the 9.53% coupon, and it does not erase the cash that has already gone out the door to Woltstone and Series A.

Disclosed financing moves after December 31, 2025

Put differently, Series B bought time, but it did not create enough new flexibility to neutralize the short-end pressure by itself. It refinanced part of the timetable into a longer bucket. It did not change the cost of capital, and it did not change the fact that Woltstone still captures both part of the project economics and part of the group's cash-control mechanics.

Covenant Room and Sponsor Support

Formally, the company is still in compliance. Equity as of December 31, 2025 was about ILS 139.3 million. The equity-to-balance-sheet ratio was 12.5%. Series A debt-to-collateral stood at 45.7% against a 65% ceiling. That is not a breach story. But capital structures are not judged only by whether there is a formal breach. They are judged by how much room is left before flexibility starts to close.

The sharper point sits in Series B. The equity threshold that triggers an interest step-up is ILS 115 million, so the cushion is only ILS 24.3 million. From year-end 2026, that threshold rises to ILS 120 million, which means the cushion would shrink to ILS 19.3 million if the December 2025 balance-sheet position stayed flat. The ratio story is similar. A 12.5% equity-to-balance-sheet ratio sounds comfortable against an 8.5% minimum, but against the year-end 2026 floor of 10%, the room is only 2.5 points, and against the 10.5% step-up trigger only 2 points.

CovenantActual at December 31, 2025Relevant thresholdCushion
Equity, Series AILS 139.3 millionMinimum ILS 75 millionILS 64.3 million
Equity, Series BILS 139.3 millionMinimum ILS 100 millionILS 39.3 million
Equity, Series B step-up triggerILS 139.3 millionILS 115 millionILS 24.3 million
Equity-to-balance-sheet ratio, Series B year-end 2026 floor12.5%Minimum 10%2.5 points
Debt-to-collateral, Series A45.7%Maximum 65%19.3 points

More important than the immediate covenant test is the distribution lock. Series A blocks distributions if equity falls below ILS 130 million or if the equity-to-balance-sheet ratio falls below 12%. Series B is tighter still, blocking distributions if equity falls below ILS 170 million or the ratio falls below 15.5%. In practice, with equity at ILS 139.3 million and the ratio at 12.5%, Series B already blocks distributions. That is protective for bondholders. For capital-structure analysis, it means every available shekel has to stay inside the balance sheet. There is no room to pull cash upward.

On top of that sits sponsor support. The controlling shareholders provided personal guarantees, without compensation, for about ILS 828 million of loans to the company and its consolidated subsidiaries, plus about ILS 172 million to equity-accounted affiliates. That is a meaningful confidence layer for lenders. But it also says something uncomfortable: the financing model still leans on the sponsors, not only on project surplus that has already been released.

Bottom Line

What this capital structure means is that Geshem Lamishtaken is not only fighting the price of money. It is fighting the order in which money gets claimed. Banks fund closed projects. Series A waits for surplus from three named projects. Series B pushes principal out to 2028 and 2029, but without collateral. Woltstone sits in the middle, both as lender and as profit participant. So the Series B expansion is a real relief, but not a release valve.

The key point is that the company is still not being tested by formal covenant breach. It is being tested by its ability to peel off layers. If the remaining Woltstone balance was in fact repaid after April 1, 2026 without eating into covenant room, and if surplus from the Series A collateral projects starts turning into released cash fast enough to replace expensive financing with internal money, the read can improve quickly. If not, the market is likely to focus less on reported gross profit and more on who gets the surplus first.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction